Individual Follow-up After Rectal Cancer - Focus on the Needs of the Patient
NCT03622437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336
Last updated 2022-06-14
Summary
With an increasing number of rectal cancer (RC) survivors, we see a rising attention to the late adverse effects following treatment of RC.
Late adverse effects that are highly prevalent and negatively impact patients' symptom burden and quality of life are: bowel-, urological and sexual dysfunctions; psychological distress; fear of recurrence. The current follow-up program primarily focuses on detection of recurrence, with less attention to late adverse effects.
In a patient-led follow-up program, the surveillance for recurrent disease is combined with detection and treatment of late adverse effects and supportive survivorship care. The follow-up involves a high degree of patient-involvement, aiming at meeting the individual patient's needs.
The patient-led follow-up programme is based on a standardized patient-education in order to enforce the patients to assess and respond sufficiently to symptoms and health problems. In case of symptoms and concerns, the patients are instructed to consult a health professional for adequate assistance and intervention.
The intervention is tested in a multicenter randomized trial, comparing the patient-led follow-up to standard routine follow-up, involving prescheduled outpatient visits.
Conditions
- Rectal Neoplasms
Interventions
- BEHAVIORAL
-
Patient-led follow-up
1. Patient-education, with information about signs of recurrent disease (alarm-symptoms), potential late effects, and how these can be managed. 2. The patients are instructed to contact a specialist nurse in case of alarm-symptoms, concerns or other problems related to the cancer disease throughout the entire follow-up period. The specialist nurse responds to the referrals, according to a standardized algorithm. In addition, all patients receive: * CEA and CT of the chest, abdomen and pelvis at 1 and 3 years after surgery * perioperative clean colon colonoscopy, and then every 5 years until the age of 75 years Only for patients with a stoma: \- access to stoma care by specialist nurses
- OTHER
-
Standard follow-up
Patients with sphincter-preserving resection: \- outpatient visits incl. rectoscopy at 6, 12, 18, 24 and 36 months Patients with rectal amputation and a permanent stoma: * outpatient visits at 3, 12 and 36 months * access to stoma care by specialist nurses All patients: * CEA and CT of the chest, abdomen and pelvis at 1 and 3 years after surgery * perioperative clean colon colonoscopy, and then every 5 years until the age of 75 years
Sponsors & Collaborators
-
Danish Cancer Society
collaborator OTHER -
Herning Hospital
collaborator OTHER -
Aalborg University Hospital
collaborator OTHER -
Randers Regional Hospital
collaborator OTHER -
Aarhus University Hospital
lead OTHER
Principal Investigators
-
Søren Laurberg, Prof. Dr.Med · Aarhus University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-26
- Primary Completion
- 2021-08-31
- Completion
- 2021-08-31
Countries
- Denmark
Study Locations
More Related Trials
-
Erectile Rating During the Treatment of Rectal Cancers Localized
NCT01843218 ·Status: COMPLETED ·Phase: NA
-
Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary
NCT06274190 ·Status: RECRUITING ·Phase: NA
-
Shared Decision Making With Anal Cancer Patients on Radiation Dose
NCT02785263 ·Status: COMPLETED ·Phase: NA
-
Rectal Sparing Approach After Preoperative Radio and/or Chemotherapy in Patients With Rectal Cancer
NCT02710812 ·Status: UNKNOWN
-
Preoperative Combined Radiation and Chemotherapy - Rectal Cancer
NCT00232453 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy
NCT00414232 ·Status: COMPLETED
-
Functional Outcome of Organ Preservation After Neo-adjuvant Chemo Radiation for Rectal Cancer
NCT02278653 ·Status: UNKNOWN
-
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
NCT04749108 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT02942563 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Efficacy of Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06314737 ·Status: COMPLETED
-
Observational Study on the Patients With Rectal Cancer
NCT02312284 ·Status: COMPLETED
-
The Development of a Patient Reported Outcomes Measure Committed to the Watch-and-wait Program for Rectal Cancer
NCT05040646 ·Status: COMPLETED
-
Implementation of a Tumor Response Assessment Program Integrating the Shared Medical Decision Into the Organ Preservation Strategy for Rectal Cancer Patients
NCT06740357 ·Status: RECRUITING ·Phase: NA
-
Treatment of Adenocarcinoma of the Rectum With Transanal Local Excision for Complete Responders
NCT03941366 ·Status: UNKNOWN ·Phase: NA
-
Watch and Wait as Treatment for Patients With Rectal Cancer
NCT03125343 ·Status: RECRUITING ·Phase: NA
-
Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
NCT05055635 ·Status: RECRUITING ·Phase: PHASE2
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
NCT05914766 ·Status: RECRUITING ·Phase: NA
-
"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.
NCT03402477 ·Status: TERMINATED
-
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
NCT00532987 ·Status: TERMINATED
-
Sexual Function and Wellbeing in Males With Rectal Cancer
NCT01216202 ·Status: COMPLETED
-
Watchful Waiting for Complete Responders to Therapy in Rectal Cancer
NCT05526079 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment
NCT05109468 ·Status: ACTIVE_NOT_RECRUITING
-
Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT06761287 ·Status: RECRUITING ·Phase: NA
-
Rectal Cancer Shared Care
NCT04966819 ·Status: UNKNOWN ·Phase: NA
-
Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy
NCT05233540 ·Status: RECRUITING